Medical Devices Startups

PanTera develops actinium-225, a therapeutic radioisotope used in precision cancer treatment through radiotheranostics, serving oncology patients and pharmaceutical companies globally. The company operates a production facility in Belgium producing high-purity actinium-225 as an active pharmaceutical ingredient for personalized nuclear medicine treatments.

5 investors

Perceptive applies AI and robotics technology to dental practice, helping dentists increase patient capacity. The company serves dental service organizations and practices seeking to modernize clinical workflows.

5 investors

A precision oncology company providing genomic testing and resources to support cancer care decisions, operating under Labcorp Oncology.

5 investors

Piramidal bridges in-vivo and in-silico intelligence for neuroscience research and clinical applications. The company develops technology that integrates biological data with computational intelligence.

5 investors

Plantiga develops wearable insole technology with integrated sensors for gait analytics and movement health monitoring. The company serves consumers and athletes seeking to improve their movement and overall health outcomes.

5 investors

Postera uses artificial intelligence and computational chemistry to accelerate drug discovery for pharmaceutical companies. The platform combines machine learning, medicinal chemistry, and software engineering to improve the drug development process.

5 investors

Precision Neuroscience develops a minimally invasive, high-bandwidth brain-computer interface, including its Layer 7 cortical interface, initially aimed at helping people with paralysis control digital devices and robotics using their thoughts. The company works with hospital clinical partners on implanted studies and positions its technology as removable and upgradable without damaging the brain.

5 investors

PredxBio analyzes spatial multi-omic tissue data to identify response-defining biology, offering a decision-intelligence platform called SpaceIQ that supports drug development from discovery through clinical trials. It serves biopharma teams with biomarker strategy, patient stratification, and trial optimization insights.

5 investors

Pretzel Therapeutics develops therapeutics targeting bioenergetic dysfunction and mitochondrial disease by addressing defects in mitochondrial DNA function and gene expression. The company leverages expertise in mitochondrial biology and drug discovery to create treatments for diseases associated with mitochondrial dysregulation.

5 investors

Prexton Therapeutics was a biopharmaceutical company developing novel therapies for Parkinson's disease, including its lead mGluR4 modulator candidate foliglurax. Acquired by Lundbeck in 2018.

5 investors

Prime Medicine develops one-time genetic therapies using Prime Editing, a gene editing technology developed in David R. Liu's lab at the Broad Institute of MIT and Harvard. The company aims to treat a broad range of genetic diseases.

5 investors

Puzzle Medical develops a heart failure treatment device designed to improve heart and kidney function through 4Fr axillary access, allowing patient ambulation and providing up to seven days of support. The technology targets early and safe treatment of heart failure.

5 investors

QSM Diagnostics develops point-of-care veterinary diagnostics for the rapid identification of bacterial infections. The company, a spinout of the Goluch Research Group at Northeastern University, builds sensors and medical devices for the veterinary market.

5 investors

Range Bio (Range Biotechnologies) develops next-generation diagnostics using translational proteomics for applications in human health. It works in high-throughput laboratory sciences.

5 investors

Stryker is a medical technology company that develops and manufactures products across areas such as orthopaedics, surgical equipment, neurotechnology, and spine care for hospitals and healthcare providers. It operates globally across the Americas, Europe, Asia-Pacific, and the Middle East.

5 investors

ReadySet provides surgical supply chain management software for hospitals, helping healthcare teams reduce delays, cut costs, and optimize surgical case workflows.

5 investors

Rejoni is a company focused on uterine health, developing technology to address women's reproductive and gynecological health needs.

5 investors

RetinaLogik makes the RVF200, a portable visual field testing headset that runs core eye exams including visual field, color vision, and acuity for use in ophthalmology and optometry clinics. A University of Calgary spin-out, its technology applies deep learning to glaucoma detection and is used by eye care providers in multiple countries.

5 investors

Scribe is a molecular engineering company developing CRISPR-based genetic therapies to treat cardiometabolic disease and other conditions. The company uses advanced engineering of natural CRISPR systems to create targeted genetic medicines.

5 investors

ShennonBio develops immunotherapy technologies using microfluidic engineering, computational biology, and immunology to advance T cell engineering for cancer treatment. The company serves therapeutic development organizations working on cell and gene therapies.

5 investors

Shinobi develops next-generation cell therapies using iPSC (induced pluripotent stem cell) research, genetic engineering, and clinical infrastructure. The company operates across Japan and the U.S., combining biotechnology and genetic engineering capabilities in cell therapy development.

5 investors

Sidewinder Therapeutics is a biotechnology company focused on oncology drug discovery and development, working on next-generation cancer treatments.

5 investors

A biopharmaceutical company that discovers, develops, and delivers medicines and vaccines, with research and development across respiratory, immunology and inflammation, oncology, HIV, and infectious diseases.

5 investors

SigTuple builds AI-powered microscopy platforms that combine robotics, microfluidics, and high-resolution imaging to automate microscopic analysis of biological samples such as blood smears for human and veterinary diagnostics. Its products serve pathologists and clinicians in point-of-care settings and clinical laboratories, with a focus on India.

5 investors